Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(18%)
Results Posted
40%(2 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_1
2
18%
Ph early_phase_1
1
9%
Ph not_applicable
2
18%
Ph phase_2
4
36%
Ph phase_3
2
18%

Phase Distribution

3

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
2(18.2%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(5)
Terminated(2)
Other(2)

Detailed Status

Completed5
unknown2
Recruiting2
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (9.1%)
Phase 12 (18.2%)
Phase 24 (36.4%)
Phase 32 (18.2%)
N/A2 (18.2%)

Trials by Status

withdrawn19%
unknown218%
recruiting218%
completed545%
terminated19%

Recent Activity

2 active trials
Showing 5 of 11
recruitingphase_2

Contrast-enhanced Ultrasound for Sentinel Node Detection

NCT07310758
recruitingphase_2

Y-90 Treatment Response Using Transarterial Radioembolization

NCT07145801
completedphase_2

Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound

NCT03245255
completedphase_2

Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection

NCT02733029
unknownnot_applicable

Added Value in Combined Use of Fusion Imaging and Contrast-enhanced Ultrasonography

NCT04487288
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07310758Phase 2

Contrast-enhanced Ultrasound for Sentinel Node Detection

Recruiting
NCT07145801Phase 2

Y-90 Treatment Response Using Transarterial Radioembolization

Recruiting
NCT03245255Phase 2

Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound

Completed
NCT02733029Phase 2

Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection

Completed
NCT04487288Not Applicable

Added Value in Combined Use of Fusion Imaging and Contrast-enhanced Ultrasonography

Unknown
NCT02968680Phase 1

Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma

Terminated
NCT02737865Not Applicable

Superb Microvascular Imaging in Focal Nodular Hyperplasia

Completed
NCT03335566Phase 3

An Efficacy and Safety Study of Sonazoid™ and SonoVue® in Participants With Focal Liver Lesions, Undergoing Pre- and Post-Contrast Ultrasound Imaging

Completed
NCT03009266Early Phase 1

Ischemic Memory Imaging With Myocardial Contrast Echocardiography

Unknown
NCT03340870Phase 1

A Study to Evaluate Pharmacokinetics of Sonazoid™ Following Intravenous Bolus Injection in Healthy Volunteers

Completed
NCT02651090Phase 3

Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced CT and/or MRI

Withdrawn

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11